Li Lu
Impact in
- Cell Biology top 2%
- Hippo pathway signaling and YAP/TAZ
- Hepatology top 5%
- Liver physiology and pathology
Papers in
-
- Wnt/β-catenin signaling in development and cancer 5
- Circular RNAs in diseases 2
-
- Hippo pathway signaling and YAP/TAZ 5
- Co-authors
- Randy L. Johnson (5 shared papers)Milton J. Finegold (2 shared papers)Ju‐Seog Lee (2 shared papers)Pu Liu (2 shared papers)Qiong Qiu (1 shared paper)Soo Mi Kim (1 shared paper)Yingdi Wang (1 shared paper)Ying Li (1 shared paper)
- Journals
- Hepatology (2 papers)Oncotarget (2 papers)PLoS ONE (2 papers)iScience (1 paper)Gene (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Lu
22 papers receiving 1.3k citations
Li Lu's Hit Papers
Peers
Comparison fields: 5 of 99
- Cell Biology 708
- Hepatology 154
- Molecular Biology 845
- Biochemistry 83
- Cancer Research 143
Countries citing papers authored by Li Lu
This map shows the geographic impact of Li Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lu more than expected).
Fields of papers citing papers by Li Lu
This network shows the impact of papers produced by Li Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lu. The network helps show where Li Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Hit paper breakdown → | 2010 | 586 |
| 2 | 2014 | 230 | |
| 3 | 2018 | 128 | |
| 4 | 2019 | 88 | |
| 5 | 2016 | 84 | |
| 6 | 2014 | 38 | |
| 7 | 2010 | 32 | |
| 8 | 2012 | 30 | |
| 9 | 2017 | 28 | |
| 10 | 2014 | 27 | |
| 11 | 2016 | 21 | |
| 12 | Panax notoginseng saponins preconditioning protects rat liver grafts from ischemia/reperfusion injury via an antiapoptotic pathway. | 2005 | 19 |
| 13 | 2009 | 17 | |
| 14 | 2019 | 13 | |
| 15 | 2021 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2025 | 4 | |
| 18 | Chromosome Number of Sladenia celastrifolia | 2001 | 3 |
| 19 | Curative effect of split low dosage total-body irradiation on murine AIDS induced by Friend virus: the results and the possible mechanism. | 1997 | 3 |
| 20 | 2021 | 3 |
About Li Lu
Li Lu is a scholar working on Molecular Biology, Cell Biology, Cancer Research, Oncology and Complementary and alternative medicine, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (5 papers), Hippo pathway signaling and YAP/TAZ (5 papers), MicroRNA in disease regulation (2 papers), Lipid metabolism and biosynthesis (2 papers), Virus-based gene therapy research (2 papers), Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cell Biology (708 citations), Hepatology (154 citations), Molecular Biology (845 citations), Biochemistry (83 citations) and Cancer Research (143 citations). Li Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Randy L. Johnson, Milton J. Finegold, Ju‐Seog Lee, Pu Liu, Qiong Qiu, Soo Mi Kim, Yingdi Wang, Ying Li, Wouter Bossuyt and Georg Halder. Their work appears in journals such as Hepatology, Oncotarget, PLoS ONE, iScience and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.